VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

bioAffinity Technologies, Inc. (BIAF) Total Return Calculator with Dividends Reinvested

bioAffinity Technologies, Inc.

Popular:

The total return for bioAffinity Technologies, Inc. (BIAF) stock is -66.77% over the past 12 months. So far it's up 73.77% this year. The 5-year total return is -99.15%, meaning $10,000 invested in BIAF stock 5 years ago would be worth $85 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in BIAF 1 year ago, it would be worth $3,504 today — you'd have lost $6,496.

With Dividends Reinvested$3,504-64.96%

Price Only (No DRIP)$3,504-64.96%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in BIAF

1Y$3,323-$6,677 (-66.8%)-66.8% CAGR

3Y$355-$9,645 (-96.4%)-67.1% CAGR

5Y$85-$9,915 (-99.1%)-61.4% CAGR

10Y$85-$9,915 (-99.1%)-37.9% CAGR

15Y$85-$9,915 (-99.1%)-27.2% CAGR

20Y$85-$9,915 (-99.1%)-21.2% CAGR

30Y$85-$9,915 (-99.1%)-14.7% CAGR

bioAffinity Technologies, Inc. did not pay dividends during this period. Total return = price return.

Loading BIAF total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+73.77%	—	+73.77%	—	$17,377
1Y	-66.77%	-66.77%	-66.77%	—	$3,323
3Y	-96.45%	-67.13%	-96.45%	—	$355
5Y	-99.15%	-61.45%	-99.15%	—	$85
10Y	-99.15%	-37.91%	-99.15%	—	$85
15Y	-99.15%	-27.22%	-99.15%	—	$85
20Y	-99.15%	-21.20%	-99.15%	—	$85
30Y	-99.15%	-14.69%	-99.15%	—	$85

Risk & Highlights

Best Year-5.77%2023

Worst Year-95.82%2025

Max Drawdown-94.74%2025-05-28 → 2026-02-05

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-13.11%	-13.11%	—	+0.41%	-13.5pp
2025	-95.82%	-95.82%	—	+16.64%	-112.5pp
2024	-46.15%	-46.15%	—	+24.00%	-70.2pp
2023	-5.77%	-5.77%	—	+24.81%	-30.6pp
2022	-80.72%	-80.72%	—	-19.95%	-60.8pp

BIAF underperformed the S&P 500 by 97.14pp over the past year (-66.77% vs +30.37%).

Loading summary...

BIAF Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
BIAFbioAffinity Technologies, Inc.	$857,186	-48.2%	+73.8%	-66.8%	—	-96.4%	-99.1%	-99.1%
LUNGPulmonx Corporation	$54M	-0.8%	-44.8%	-65.5%	—	-89.8%	-97.0%	-96.8%
NVCRNovoCure Limited	$1.9B	+62.6%	+28.3%	+1.1%	—	-75.7%	-91.3%	+30.3%
CDNACareDx, Inc	$1.1B	+21.3%	+12.0%	+45.2%	—	+161.1%	-72.4%	+385.1%
EXASExact Sciences Corporation	$20.0B	—	+3.1%	+96.9%	—	+53.0%	+0.4%	+1669.1%
GKOSGlaukos Corporation	$7.9B	+16.6%	+21.2%	+52.0%	—	+128.7%	+61.5%	+457.1%
ILMNIllumina, Inc.	$21.1B	+9.7%	+3.2%	+81.7%	—	-27.1%	-62.8%	+0.7%
TMOThermo Fisher Scientific Inc.	$176.4B	-3.1%	-19.8%	+16.8%	+0.4pp	-11.7%	+2.8%	+229.1%
DHRDanaher Corporation	$124.3B	-8.0%	-23.6%	-8.3%	+0.7pp	-15.5%	-21.1%	+219.3%
BIOBio-Rad Laboratories, Inc.	$6.9B	-7.4%	-15.7%	+10.7%	—	-32.0%	-57.7%	+81.4%
HOLXHologic, Inc.	$17.0B	+0.0%	+1.9%	+37.1%	—	-8.5%	+15.8%	+124.3%

Compare:BIAF vs LUNG BIAF vs NVCR BIAF vs CDNA BIAF vs LUNG vs NVCR

About BIAF Dividend Returns

bioAffinity Technologies, Inc. (BIAF) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of BIAF over the past year?

bioAffinity Technologies, Inc. (BIAF) delivered a return of -66.77% over the past year. Since BIAF does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in BIAF be worth today?

A $10,000 investment in bioAffinity Technologies, Inc. one year ago would be worth $3,323 today, representing a loss of $6,677.

Q3Does BIAF pay dividends?

bioAffinity Technologies, Inc. (BIAF) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BIAF, the total return equals the price-only return.

Q4Did BIAF beat the S&P 500?

No, bioAffinity Technologies, Inc. (BIAF) underperformed the S&P 500 by 97.14 percentage points over the past year. BIAF delivered a total return of -66.77%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed BIAF by 97.14pp during this period.

Q5What is BIAF's worst drawdown?

bioAffinity Technologies, Inc. (BIAF) experienced a maximum drawdown of -94.74% over the past year, declining from its peak on 2025-05-28 to its trough on 2026-02-05. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is BIAF's long-term total return over 10, 20, or 30 years?

Here are bioAffinity Technologies, Inc. (BIAF)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.1% (-37.9% CAGR) — $10,000 would have grown to $85. Over 20 years: -99.1% total return (-21.2% CAGR) — $10,000 → $85. Over 30 years: -99.1% total return (-14.7% CAGR) — $10,000 → $85. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was BIAF's best and worst year?

bioAffinity Technologies, Inc.'s best calendar year was 2023 with a total return of -5.8%. Its worst year was 2025 with a total return of -95.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 90.0 percentage points.